STERIS (STE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual General Meeting scheduled for July 31, 2025, with proxy materials available online or by request.
Shareholders are encouraged to review the proxy statement, annual report, and financial statements before voting.
Voting matters and shareholder proposals
Election of ten directors is proposed, with individual nominees listed.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending March 31, 2026.
Appointment and remuneration of Ernst & Young Chartered Accountants as statutory auditor under Irish law.
Advisory vote on executive compensation for named executive officers.
Renewal of Board authority to issue shares and to opt-out of statutory pre-emption rights under Irish law.
Provision to transact other business as may arise at the meeting.
Board of directors and corporate governance
Board recommends all proposals and nominees for director positions.
Board or Audit Committee authorized to determine auditor remuneration.
Latest events from STERIS
- Q3 revenue and EPS up 9%, outlook steady despite tariff and Q4 headwinds.STE
Q3 20266 Feb 2026 - Revenue up 8.1% to $1.28B, adjusted EPS at $2.03, and full-year outlook reaffirmed.STE
Q1 20252 Feb 2026 - Strong U.S. healthcare volumes and recurring revenue drive growth amid evolving global trends.STE
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q2 revenue up 7.3% and adjusted EPS at $2.14; FY25 outlook reaffirmed.STE
Q2 202515 Jan 2026 - Q3 revenue up 6% and adjusted EPS rises to $2.32; outlook narrowed on currency headwinds.STE
Q3 20258 Jan 2026 - Shareholders to vote on director re-elections, auditor appointments, and executive pay amid strong growth.STE
Proxy Filing1 Dec 2025 - Shareholders to vote on key governance, compensation, and capital proposals after a year of strong growth.STE
Proxy Filing1 Dec 2025 - Key votes include director re-election, auditor ratification, and executive pay approval.STE
Proxy Filing1 Dec 2025 - Dr. Steeves retires from the board; all other proxy items and nominees remain unchanged.STE
Proxy Filing1 Dec 2025